Opinion: Will Bayer rue Monsanto purchase?

Ironically I was on some R-and-R in St. Louis, headquarters to Monsanto, when a California jury dropped the mother of all H-bombs on Bayer’s newest acquisition:  Monsanto’s flagship weed killer Roundup contributed to high school groundsman Dewayne Johnson’s non-Hodgkins lymphoma. Put bluntly the jury ruled Roundup causes cancer and it awarded terminally-ill Johnson $39 million in compensatory and $250 million in punitive damages.  Yup $289 million total. Bayer, which purchased Monsanto just two months ago, has taken a massive financial hit, losing more than 10 percent of share value. So how did Monsanto and Bayer lose?

Opinion: Lawsuits moving forward on whether Monsanto’s Roundup cause cancer

Bayer’s announcement that it is terminating the Monsanto brand as part of its takeover of the St. Louis agri-business company unfortunately won’t come close to ending controversies surrounding Monsanto. Can you say clean up on aisle four? One needs to look no further than the massive cancer trial that got underway in early July  to understand the huge stakes Bayer is facing. The trial – in a nutshell – is whether or not California native DeWayne “Lee”Johnson developed non-Hodgkin’s lymphoma from exposure to Monsanto’s flagship product weedkiller Roundup.  Johnson sprayed the chemical for years as part of his jobs serving as a goundskeeper for a school district in Benicia, California.

Opinion: Will farmers regret Bayer and Monsanto going to the chapel?

Despite Bayer’s $66 billion move  – yeah with a B –  to acquire Monsanto, there remains serious doubt among some advocates that the U.S. Department of Justice did not do enough to protect  farmers and other stakeholders from escalating seed and chemical costs and the unappetizing possibility of fewer choices at the retail marketplace.

Big Ag salary guide: Dow, Monsanto, ADM lead the way

Over the past three years, these companies have on average paid their executives and directors more than $100 million, according to a Midwest Center for Investigative Reporting review of financial filings. The median was $94.5 million.